Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT México, posted on LinkedIn:
“I’m pleased to share that my abstract was accepted for online presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.
Our work, titled ‘Progesterone receptor expression and survival outcomes in metastatic breast cancer’, explores the prognostic role of PR status in the metastatic setting.
Grateful to the entire team and looking forward to contributing to this year’s scientific discussions.”
Sergio Cifuentes Canaval will present his abstract at the 2025 ASCO Annual Meeting. The study investigates how progesterone receptor expression influences survival outcomes in metastatic breast cancer, contributing to ongoing research on hormone receptor profiling in advanced disease.